CAR T cells targeting CD99 as an approach to eradicate T-cell acute lymphoblastic leukemia without normal blood cells toxicity
2021 · Journal of Hematology & Oncology · 52 citations
https://doi.org/10.1186/s13045-021-01178-z
H
Hong Cen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
188
Citations
6
h-index
5
i10-index
Hong Cen is an academic researcher from Guangxi Medical University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & Acute Lymphoblastic Leukemia research. The author has an h-index of 6, co-authored 63 publications.
ORCID: 0000-0003-2232-9213Papers by this author
worksAssociation of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.14790046
Real-World Outcomes of Equecabtagene Autoleucel, the First Fully Human BCMA-Targeted CAR-T Therapy, in 150 Patients with Multiple Myeloma (MM): A Multicenter Experience from China
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)03530-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat